Sinus node inhibitors

A new concept in angina pectoris

Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology, Specialties, Internal Medicine, Cardiology
Cover of the book Sinus node inhibitors by , Steinkopff
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783642724589
Publisher: Steinkopff Publication: December 6, 2012
Imprint: Steinkopff Language: English
Author:
ISBN: 9783642724589
Publisher: Steinkopff
Publication: December 6, 2012
Imprint: Steinkopff
Language: English

Although surgical and catheter-based revascularization techniques have substan­ tially improved today's therapeutic potential in ischemic heart disease, in the majority of patients treatment will be conservative for a number of reasons, the cost-effectiveness of non-pharmacological approaches being of major importance. During the last two decades, drug development for ischemic heart disease has been impressive and many new compounds have been added to our therapeutic armamentarium. Nevertheless, where mode of action is concerned, it is interesting to note that, despite all these efforts, we are still confined to three categories of drugs. Antithrombotics and platelet-active agents aside, these concern nitrates, betablocking drugs and calcium antagonists, agents which reduce ischemia by diminishing cardiac work or wall stress,. thereby affecting myocardial oxygen demand and/or by improving coronary blood flow. Alone or in combination, these agents have proved to be efficacious in the treatment of angina pectoris or other symptoms of ischemic heart disease in a number of patients, but certainly not in all. Moreover, as side-effects are often a problem with current antianginal compounds, the physician may find himself restricted in his therapeutic capabilities and in need of new and, preferably, alternative forms of pharmacological treatment.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Although surgical and catheter-based revascularization techniques have substan­ tially improved today's therapeutic potential in ischemic heart disease, in the majority of patients treatment will be conservative for a number of reasons, the cost-effectiveness of non-pharmacological approaches being of major importance. During the last two decades, drug development for ischemic heart disease has been impressive and many new compounds have been added to our therapeutic armamentarium. Nevertheless, where mode of action is concerned, it is interesting to note that, despite all these efforts, we are still confined to three categories of drugs. Antithrombotics and platelet-active agents aside, these concern nitrates, betablocking drugs and calcium antagonists, agents which reduce ischemia by diminishing cardiac work or wall stress,. thereby affecting myocardial oxygen demand and/or by improving coronary blood flow. Alone or in combination, these agents have proved to be efficacious in the treatment of angina pectoris or other symptoms of ischemic heart disease in a number of patients, but certainly not in all. Moreover, as side-effects are often a problem with current antianginal compounds, the physician may find himself restricted in his therapeutic capabilities and in need of new and, preferably, alternative forms of pharmacological treatment.

More books from Steinkopff

Cover of the book Nutrition and Caries by
Cover of the book Clinical Results of Synovectomy in Rheumatoid Arthritis by
Cover of the book From Molecule to Men by
Cover of the book Predisposing Conditions for Acute Ischemic Syndromes by
Cover of the book Search for the Causes of Schizophrenia by
Cover of the book Critical Limb Ischemia Carotid Surgery by
Cover of the book Mild Hypertension by
Cover of the book Functional Morphology of the Endocrine Heart by
Cover of the book Interventional Cardiology and Angiology by
Cover of the book Adrenergic Mechanisms in Myocardial Ischemia by
Cover of the book Cardiac Glycosides 1785–1985 by
Cover of the book Liquid Crystals by
Cover of the book New and Upcoming Markers of Alcohol Consumption by
Cover of the book Cardiac Valve Allografts 1962–1987 by
Cover of the book Current Problems in PTCA by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy